Alimta side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Alimta. Common side effects include death among females, and death among males.

The phase IV clinical study is created by eHealthMe based on 7,645 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 23, 2023

7,645 people who take Alimta and have side effects are studied.

What is Alimta?

Alimta has active ingredients of pemetrexed disodium. Currently, eHealthMe is studying from 7,702 Alimta users.

Number of Alimta reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Alimta?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on pemetrexed disodium (the active ingredients of Alimta) and Alimta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Alimta:

Alimta (7,702 reports)

Common Alimta side effects:

Thrombocytopenia (decrease of platelets in blood): 711 reports
Death: 691 reports
Rashes (redness): 456 reports
Breathing difficulty: 424 reports
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 418 reports

All Alimta side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

How effective is Hydroxyzine for Stress And Anxiety? - 4 seconds ago
Azathioprine and Purulent Discharge - 12 seconds ago
Glipizide and Actrapid drug interaction - 19 seconds ago
Sertraline and Common Peroneal Nerve Dysfunction - 22 seconds ago
Omeprazole Magnesium and Acetaminophen drug interaction - 34 seconds ago
Armour Thyroid and Hypokalemia - 35 seconds ago
Versed and Pravachol drug interaction - 39 seconds ago
Femara and Electrolyte Imbalance - 49 seconds ago
Cialis and Clozapine drug interaction - 52 seconds ago
Mucinex Dm and Wrist Fracture - 52 seconds ago